Clinical Pharmacology & Therapeutics · 2001 · 260 citations · 19 references
At optimized steady state, individual sensitivity to warfarin is determined by CYP2C9 genotype and age with no effect of vitamin K. Prospective studies will determine the impact of these findings in clinical practice.
19
Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation
Elaine M. Hylek · JAMA · 1998 · 377 citations
Genetic association between sensitivity to warfarin and expression of CYP2C9*3
Daniel J. Steward, Robert L. Haining, Kirk R. Henne et al. · Pharmacogenetics · 1997 · 307 citations
Genetic analysis of the human cytochrome P450 CYP2C9 locus
Michael J. Stubbins, Lorna W. Harries, Gillian Smith et al. · Pharmacogenetics · 1996 · 303 citations